SSI Weekly Highlights: Liquidations, Mergers, and Strategic Developments in Biopharma

288 Views10 Mar 2025 01:54
Abrdn Diversified Income And Growth is undergoing a wind-down, trading at a 30% discount to NAV, with potential liquidation acceleration.
What is covered in the Full Insight:
  • Abrdn Diversified Income And Growth
  • Acelyrin - Merger Arbitrage
  • Sage Therapeutics - Lawsuit and CMO Resignation
  • OCI N.V. - Methanol Sale Update
  • Pacific Current Group - Tender Extension
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
    Loading
Trending Collections
More »
    Loading
Trending Insights
More »
    Loading
Top Unpaywalled Insights
More »
    Loading
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • SSI Weekly Highlights: Liquidations, Mergers, and Strategic Developments in Biopharma
    10 Mar 2025
x